TNFSF10 and cholangiocarcinoma: miR-25: the earliest support for the oncogenic role of miR-25 in BTC was a publication by Razumilawa et al. which highlighted that miR-25 promoted resistance to apoptosis in CCA cells via TNF related apoptosis inducing ligand (TRAIL) [71].